Is there any effect of first-day usage of a totally implantable venous access device on complications?
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605490511 | ||
| 003 | CHVBK | ||
| 005 | 20210128100505.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20151201xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10147-015-0830-7 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10147-015-0830-7 | ||
| 245 | 0 | 0 | |a Is there any effect of first-day usage of a totally implantable venous access device on complications? |h [Elektronische Daten] |c [Hasan Karanlik, Hatice Odabas, Ilknur Yildirim, Ilker Ozgur, Berkay Kilic, Fatma Sen, Sidika Kurul, Adnan Aydiner] |
| 520 | 3 | |a Background: Our aim was to evaluate whether it is safe to use a totally implantable venous access device (TIVAD) on the day of implantation. Methods: We investigated data from 1315 cancer patients divided into two groups according to the time interval between TIVAD placement and the first use of the TIVAD to adminster chemotherapy: patients whose devices were used during the first 24h after placement were enrolled into group 1 and patients whose devices were first used more than 24h after device placement were enrolled into group 2. Results: Early complications were all related to device insertion and occurred before chemotherapy administration. Infection and venous thrombosis were the most frequent complications during the first 6months after TIVAD insertion in both groups. However, the frequency of late complications was statistically the same for the two groups. Conclusions: The early use of TIVADs appears safe. Usage of the catheter for chemotherapy administration during the first 24h after insertion has no effect on the rate of complications. | |
| 540 | |a Japan Society of Clinical Oncology, 2015 | ||
| 690 | 7 | |a Catheter |2 nationallicence | |
| 690 | 7 | |a First use |2 nationallicence | |
| 690 | 7 | |a Totally implantable venous access device |2 nationallicence | |
| 700 | 1 | |a Karanlik |D Hasan |u Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey |4 aut | |
| 700 | 1 | |a Odabas |D Hatice |u Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey |4 aut | |
| 700 | 1 | |a Yildirim |D Ilknur |u Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey |4 aut | |
| 700 | 1 | |a Ozgur |D Ilker |u Department of Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey |4 aut | |
| 700 | 1 | |a Kilic |D Berkay |u Department of Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey |4 aut | |
| 700 | 1 | |a Sen |D Fatma |u Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey |4 aut | |
| 700 | 1 | |a Kurul |D Sidika |u Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey |4 aut | |
| 700 | 1 | |a Aydiner |D Adnan |u Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey |4 aut | |
| 773 | 0 | |t International Journal of Clinical Oncology |d Springer Japan |g 20/6(2015-12-01), 1057-1062 |x 1341-9625 |q 20:6<1057 |1 2015 |2 20 |o 10147 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10147-015-0830-7 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10147-015-0830-7 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Karanlik |D Hasan |u Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Odabas |D Hatice |u Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Yildirim |D Ilknur |u Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Ozgur |D Ilker |u Department of Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kilic |D Berkay |u Department of Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Sen |D Fatma |u Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kurul |D Sidika |u Surgical Oncology Unit, Institute of Oncology, Istanbul University, Capa, Istanbul, Turkey |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Aydiner |D Adnan |u Division of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t International Journal of Clinical Oncology |d Springer Japan |g 20/6(2015-12-01), 1057-1062 |x 1341-9625 |q 20:6<1057 |1 2015 |2 20 |o 10147 | ||